Concepedia

Sylvia J. Degrado

SJ

Statistics

Publications

15

Citations

1.8K

H-Index

14

Active since

1998

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Boston College

Abzena (United States)

Sylvia J. Degrado is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in drug discovery, pharmacology, and medicinal chemistry.

Publications per year

1998–2017

15

Publications

15

Rapid Identification of Subtype-Selective Agonists of the Somatostatin Receptor Through Combinatorial Chemistry

Susan P. Rohrer, Elizabeth T. Birzin, Ralph T. Mosley et al. · Science · 1998 · 461 citations

, , +17

Eradication of Tumors through Simultaneous Ablation of CD276/B7-H3-Positive Tumor Cells and Tumor Vasculature

Steven Seaman, Zhongyu Zhu, Saurabh Saha et al. · Cancer Cell · 2017 · 447 citations

, , +14

Modular Peptide-Based Phosphine Ligands in Asymmetric Catalysis:  Efficient and Enantioselective Cu-Catalyzed Conjugate Additions to Five-, Six-, and Seven-Membered Cyclic Enones

Sylvia J. Degrado, Hirotake Mizutani, Amir H. Hoveyda · Journal of the American Chemical Society · 2001 · 250 citations

, , +7

Cu-Catalyzed Asymmetric Conjugate Additions of Alkylzinc Reagents to Acyclic Aliphatic Enones

Hirotake Mizutani, Sylvia J. Degrado, Amir H. Hoveyda · Journal of the American Chemical Society · 2002 · 193 citations

, , +11

Highly Enantioselective Cu‐Catalyzed Conjugate Additions of Dialkylzinc Reagents to Unsaturated Furanones and Pyranones: Preparation of Air‐Stable and Catalytically Active Cu–Peptide Complexes

M. Kevin Brown, Sylvia J. Degrado, Amir H. Hoveyda · Angewandte Chemie International Edition · 2005 · 130 citations

, , +8

1–5 of 15